electroCore (ECOR) Competitors $9.94 -0.15 (-1.49%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ECOR vs. RMTI, IRIX, ZYXI, ELMD, LUNG, SKIN, PROF, SGHT, ZJYL, and SONXShould you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Rockwell Medical (RMTI), IRIDEX (IRIX), Zynex (ZYXI), Electromed (ELMD), Pulmonx (LUNG), Beauty Health (SKIN), Profound Medical (PROF), Sight Sciences (SGHT), Jin Medical International (ZJYL), and Sonendo (SONX). electroCore vs. Rockwell Medical IRIDEX Zynex Electromed Pulmonx Beauty Health Profound Medical Sight Sciences Jin Medical International Sonendo Rockwell Medical (NASDAQ:RMTI) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Is RMTI or ECOR more profitable? Rockwell Medical has a net margin of -1.25% compared to electroCore's net margin of -54.40%. Rockwell Medical's return on equity of 8.55% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets Rockwell Medical-1.25% 8.55% 3.80% electroCore -54.40%-154.45%-69.16% Which has more risk & volatility, RMTI or ECOR? Rockwell Medical has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Do insiders & institutionals have more ownership in RMTI or ECOR? 23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 1.9% of Rockwell Medical shares are owned by company insiders. Comparatively, 19.7% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has preferable valuation and earnings, RMTI or ECOR? Rockwell Medical has higher revenue and earnings than electroCore. Rockwell Medical is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRockwell Medical$83.61M0.90-$8.44M-$0.05-46.60electroCore$16.03M4.06-$18.83M-$1.83-5.43 Does the media favor RMTI or ECOR? In the previous week, electroCore had 3 more articles in the media than Rockwell Medical. MarketBeat recorded 16 mentions for electroCore and 13 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 0.70 beat electroCore's score of 0.13 indicating that Rockwell Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 2 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive electroCore 6 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor RMTI or ECOR? Rockwell Medical received 144 more outperform votes than electroCore when rated by MarketBeat users. However, 62.12% of users gave electroCore an outperform vote while only 57.68% of users gave Rockwell Medical an outperform vote. CompanyUnderperformOutperformRockwell MedicalOutperform Votes30857.68% Underperform Votes22642.32% electroCoreOutperform Votes16462.12% Underperform Votes10037.88% Do analysts rate RMTI or ECOR? Rockwell Medical currently has a consensus price target of $7.00, indicating a potential upside of 200.43%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts plainly believe Rockwell Medical is more favorable than electroCore.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33electroCore 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryRockwell Medical beats electroCore on 13 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get electroCore News Delivered to You Automatically Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ECOR vs. The Competition Export to ExcelMetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$65.11M$3.38B$5.06B$8.82BDividend YieldN/A1.65%5.17%4.07%P/E Ratio-5.4319.00125.9917.81Price / Sales4.0688.021,180.3874.38Price / CashN/A46.1733.8232.53Price / Book8.023.734.684.68Net Income-$18.83M$92.21M$119.54M$226.08M7 Day Performance-25.82%-5.18%-2.45%-2.04%1 Month Performance23.63%7.91%-4.06%0.06%1 Year Performance62.68%20.84%29.86%24.60% electroCore Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ECORelectroCore0.8003 of 5 stars$9.94-1.5%N/A+62.7%$66.14M$16.03M-5.4350Analyst RevisionRMTIRockwell Medical4.2639 of 5 stars$2.33-6.4%$7.00+200.4%+19.5%$80.47M$83.61M-46.60300Analyst DowngradeIRIXIRIDEX0.6935 of 5 stars$1.74-2.2%$2.00+14.9%-17.1%$29.61M$51.87M0.00120ZYXIZynex3.7354 of 5 stars$7.86+0.5%$14.00+78.1%-12.6%$249.03M$184.32M52.401,100ELMDElectromedN/A$29.21+4.6%N/A+181.9%$247.06M$57.06M40.57174LUNGPulmonx2.5845 of 5 stars$6.20+3.3%$14.67+136.6%-42.9%$236.93M$68.68M0.00250SKINBeauty Health2.6897 of 5 stars$1.49-7.5%$2.55+71.1%-36.3%$200.29M$398M0.001,030Analyst RevisionPositive NewsPROFProfound Medical2.4531 of 5 stars$7.69-1.8%$13.75+78.8%-31.2%$193.10M$7.20M0.00150Positive NewsSGHTSight Sciences2.5151 of 5 stars$3.73-1.1%$5.50+47.5%+63.6%$191.35M$81.06M0.00210ZJYLJin Medical InternationalN/A$1.01-16.5%N/A-94.1%$187.55M$19.82M0.00245Positive NewsGap DownHigh Trading VolumeSONXSonendoN/A$2.16+1.4%N/A+815.3%$180.60M$44.40M-4.80250Positive NewsGap Up Related Companies and Tools Related Companies RMTI Competitors IRIX Competitors ZYXI Competitors ELMD Competitors LUNG Competitors SKIN Competitors PROF Competitors SGHT Competitors ZJYL Competitors SONX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ECOR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding electroCore, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share electroCore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
